This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

Artificial Intelligence in Aortic Regurgitation

Sponsored by Chinese University of Hong Kong

About this trial

Last updated 3 months ago

Study ID

2024.689-T

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18+ Years
All Sexes

Trial Timing

Started 6 months ago

What is this trial about?

This research project aims to develop and validate a tool that uses artificial intelligence (AI) to automatically detect and quantify aortic regurgitation (AR). The clinical efficacy of this tool will be established by comparing it to manual diagnostic methods in a multicenter randomized controlled trial. By leveraging deep learning (DL) techniques, the AI system will automate aortic regurgitation (AR) detection, measurement, and diagnosis, addressing challenges like variability in echocardiographic interpretations and the need for specialized expertise. It will integrate multiple echocardiographic parameters to provide accurate, standardized, and efficient AR diagnoses, reducing human error and improving consistency. This tool will enhance diagnostic precision and accessibility, improving clinical outcomes and extending advanced diagnostic capabilities to a broader range of healthcare environments, including resource-limited settings.

What are the participation requirements?

Inclusion Criteria

* Confirmed AR diagnosis via TTE and Doppler imaging per guidelines.

* Age ≥ 18 years.

* Adequate acoustic window for AR quantification.

Exclusion Criteria

* Prior cardiac transplant or implanted cardiac devices.

* Poor image quality.

* Pregnancy or lactation.